American Diabetes Association Guide to Nutrition Therapy for Diabetes. Marion J. Franz

      Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes. Metabolism 41:768–771, 1992

      Althius MD, Jordon NE, Ludington EA, Wittes JT: Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 76:148–155, 2002

      American Diabetes Association: Nutrition recommendations and interventions for diabetes (Position Statement). Diabetes Care 31 (Suppl. 1):S61–S78, 2008

      American Diabetes Association: Standards of medical care in diabetes: 2012. Diabetes Care 35 (Suppl. 1):S11–S63, 2012

      Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O’Brien PC, Reljanovic M, Samiqullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group: The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26:770–776, 2003

      Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:1786–1791, 1997

      Angell M, Kassirer JP: Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 339:839–841, 1998

      Arquilla ER, Packer S, Tarmas W, Miyamoto S: The effect of zinc on insulin metabolism. Endocrinology 103:1440–1449, 1978

      Balk EM, Tatsioni A, Lichtensetin AH, Lau J, Pittas AG: Effect of chromium supplementation on glucose metabolism and lipids. Diabetes Care 30:2154–2163, 2007

      Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 24:39–52, 2003

      Beitner H: Randomized, placebo controlled, double-blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin. Br J Dermatol 149:841–849, 2003

      Bland R, Markovic D, Hills CE, Hughes SV: Expression of 25-hydroxyvitamin D3-1 alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 121:89–90, 2004

      Blostein-Fujii A, DiSilvestro RA, Frid D, Katz C, Malarkey W: Short-term zinc supplementation in women with non-insulin dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr 66:639–642, 1997

      Boden G, Chen X, Ruiz J, van Rossum GD, Turco S: Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin dependent diabetes mellitus. Metabolism 45:1130–1135, 1996

      Bohl CH, Volpe SL: Magnesium and exercise. Crit Rev Food Sci Nutr 42:533–563, 2002

      Bond JS, Failla ML, Unger DF: Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. J Biol Chem 258:8004–8009, 1983

      Cefalu WT, Hu FB: Role of chromium in human health and in diabetes. Diabetes Care 27:2741–2751, 2004

      Ceriello A: The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 (Suppl. 1):M9–M16, 2003

      Chehade JM, Sheikh-Ali M, Mooradian AD: The role of micronutrients in managing diabetes. Diabetes Spectrum 22:214–218, 2009

      Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820–825, 2004

      Cohen N, Halberstam M, Schilmovich P, Chang CJ, Shamoon H, Rosetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J Clin Invest 95:2501–2509, 1995

      Davies S, Howard JM, Hunnisett A, Howard M: Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients: implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46:469–473, 1997

      de Leeuw I, Engelen W, De Block C, Van Gaal L: Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1DM). Magnes Res 17:109–114, 2004

      de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V: The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21:682–686, 1998

      de Valk HW, Verkaaik R, Van Rijn HJ, Geerdink RA, Struyvenberg A: Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 15:503–507, 1998

      Dietary Supplement Health and Education Act of 1994 (DSHEA). Public Law 103-417

      Dong J-Y, Xun P, He K, Qin L-Q: Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34:2116–2122, 2011

      Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G: Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 18:188–192, 1995

      Elliott RB, Pilcher CC, Fergusson DM, Stewart AW: A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrinol Metab 9:501–509, 1996

      Erlinger TP, Guallar E, Miller ER, Stolzenberg-Solomon R, Appel LJ: Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med 161:1903–1908, 2001

      European Nicotinamide Diabetes Intervention Trial Group: European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomized controlled trial of intervention before the onset of diabetes. Lancet 363:925–931, 2004

      Everson GJ, Shrader RE: Abnormal glucose tolerance in manganese deficient guinea pigs. J Nutr 94:89–94, 1968

      Failla ML, Kiser RA: Hepatic and renal metabolism of copper and zinc in the diabetic rat. Am J Physiol 244:E115–E121, 1983

      Food and Drug Administration: Food labeling: mandatory status of nutrition labeling and nutrient content, revision, format for nutrition label. Federal Register 58:2151, 1993a

      Food and Drug Administration: Regulation of dietary supplements. Federal Register 58:33692, 1993b

      Food and Nutrition Board, Institute of Medicine, National Academy of Sciences: Recommended Dietary Allowances. 10th ed. Washington, DC, National Academies Press, 1989

      Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228–1230, 2005

      Fox GN, Sabovic Z: Chromium picolinate supplementation for diabetes mellitus. J Fam Pract 46:83–86, 1998

      Franz MJ: 2002 Diabetes nutrition recommendations: grading the evidence. Diabetes Educ 28:756–766, 2002

      Franz MJ: Micronutrients and diabetes. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 1999, p. 165–191

      Garg A, Grundy SM: Nicotinic acid as therapy for dyslipidemia in noninsulin-dependent diabetes. JAMA 264:723–726, 1990

      Goldfine A, Simonson D, Folli F, Patti ME, Kahn R: Metabolic effects of sodium metavanadate in humans with insulin-dependent and non-insulin dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311–3320, 1995

      Guerrero-Romero F, Rodriquez-Moran M: Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 36:250–257, 2005

      Guerrero-Romero F, Rodriguez-Moran M: Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39:209–213, 2002

      Guerrero-Romero